aspirin has been researched along with arachidonyl-2-chloroethylamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fereniec-Gołtbiewska, L; Rutkowska, M | 1 |
Fereniec-Gołebiewska, L; Rutkowska, M | 1 |
2 other study(ies) available for aspirin and arachidonyl-2-chloroethylamide
Article | Year |
---|---|
ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB1 receptor agonist, protects against aspirin-induced gastric ulceration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arachidonic Acids; Aspirin; Dose-Response Relationship, Drug; Gastric Mucosa; Ranitidine; Rats; Receptor, Cannabinoid, CB1; Stomach Ulcer | 2006 |
Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arachidonic Acids; Arginine; Aspirin; Enzyme Inhibitors; Female; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Stomach Ulcer | 2009 |